Introduction
The depletion of the protein compartment by disease or treatment correlates with poor clinical outcomes in hospitalized patients. To identify these patients, investigators use weight loss, serum protein levels, body mass index (BMI), subjective global assessment, anthropometric measurements, fat-free mass (FFM), muscle function, and combinations of these measurements to predict clinical outcome with varied success. However, reproducibility of most predictors is inconsistent, and thus research to identify consistent criteria is needed to 592672P ENXXX10.1177/0148607115592672Journal of Parenteral and Enteral NutritionKudsk et al research-article2015 detect malnutrition, particularly alterations in the protein compartment to allow identification and treatment of nutritionally at-risk individuals.
With the advent of bioelectric impedance analysis (BIA), clinical assessment of the protein-rich FFM compartment became more widespread due to its low cost, portability, and safety, making it ideal for clinical trials. For example, FFM successfully identified patients with cancer at risk of postoperative complications. Fritz et al 1 studied 115 patients with gastrointestinal (GI) cancer and noted the "average physical characteristics of the patients were within normal range with a wide range of variation." They reported that while the magnitude of the surgical procedure influenced outcome, a history of weight loss and the deficit relative to "normal values" of FFM adjusted by age and sex identified patients at risk of serious postoperative complications, which is similar to our prior work. 2 Moreover, patients with a negative FFM trajectory (ie, weight loss by history) sustained a significantly higher complication rate than patients with a positive FFM trajectory. However, the use of BIA to measure FFM is limited by the wide range of normal values, including age, height, and numerous other factors. 3 VanItallie et al 4 recommended the use of the fat-free mass index (FFMI) in place of FFM alone, in which the measured FFM is indexed by height. These authors argued that FFMI would parallel BMI and thus should be relatively independent of height, sex, and age. They studied FFMI and the FFMI percentiles as predictors of nutrition depletion by comparing the 50th percentile of a healthy population with those experiencing 24 weeks of semi-starvation in the classic Keys study of conscientious objectors. 5 Starved subjects exhibited significant decreases in FFMI with advancing weeks of food deprivation, decreasing below the 5th percentile at semi-starvation week 24; refeeding resulted in an increase in both FFMI and FFMI percentiles. This study suggests the clinical usefulness of FFMI to identify nutrition depletion. The reference population used by VanItallie et al, however, was small and not nationally representative.
BIA measurements of FFM and FFMI have predicted negative outcomes in groups of Swiss hospital patients using Swiss population norms, 6 but similar normative data do not exist for the U.S. population. This study uses anthropomorphic data from the National Health and Nutrition Examination Survey (NHANES) 7 to generate normative values of FFM and FFMI for the U.S. population. The expectation is that these data will be useful in subsequent prospective studies of patients using BIA or multifrequency BIA as a measure of protein-rich tissue in pre-and postintervention trials.
Participants and Methods
The NHANES III data, available online at http://www.cdc. gov/nchs/nhanes.htm, served as the data set as approved by the NHANES Institutional Review Board. The NHANES provides body measurements, health, and nutrition data for the noninstitutionalized U.S. population. The NHANES III (1988) (1989) (1990) (1991) (1992) (1993) (1994) survey obtained weight, height, BMI, and anthropometric measurements from >30,000 individuals from 2 months to 99 years of age, including BIA. Approximately 16,000 participants across all age groups in this population underwent BIA measurements. The NHANES III data set (1988-1994) was selected because it includes a large amount of BIA data for males and females aged 12 to >90 years. BIA was measured in the NHANES III sample population using a Valhalla 1990B BioResistance Body Composition Analyzer (Valhalla Scientific, San Diego, CA) at 50 kHz as part of the physician examination, using a random procedure to recruit participants. 7 Data from youth and adult demographic files (including age, sex, and race/ethnicity) of participants 12 years and older were combined into one data set. The identification number (SEQN) linked participants from these files to the examination components that included anthropometric and resistance values (height, weight, BMI, and resistance). We omitted participants with missing height, weight, BMI, or resistance values and participants with race/ethnicity of "other" from analysis.
BIA uses a drop in voltage due to resistance and reactance (impedance) from body tissues to determine impedance and estimate fat-free and fat mass. 8 Several available devices measure BIA resistance, but the resultant data lie on different scales. Since the BIA data in NHANES III were generated with a Valhalla device, and the validated prediction equations for U.S. FFM were developed with an RJL device, 9 Valhalla resistance measures were converted to RJL resistances using the widely accepted formula of Chumlea et al 10 :
For where weight = weight in kilograms, S = stature in centimeters, and Res = corrected RJL resistance in ohms. We normalized FFM by height to create the FFMI: FFM/Ht 2 , where FFM is in kilograms and Ht in meters. These equations were validated in their development using a multicomponent body composition model with cross-validation based on densitometry from underwater weighting, total body water from isotope dilution, and total body bone mineral content using dual-energy x-ray absorptiometry. 9 
Statistical Analysis
Nonparametric quantile regression 11, 12 was used to model the 2.5, 5, 10, 25, 50, 75, 90, 95, and 97.5 percentiles as a function of sex, age (in years), and race/ethnicity (non-Hispanic white, non-Hispanic black, Mexican American). A cubic B-spline basis was used for age, with knots at 14 [2] 22, 25, and 30 [10] 80 years (ie, from 14-22 in increments of 2). Terms were entered additively into the model. Separate models were fitted to unrestricted BMI and to BMI in the [18.5-30) range (ie, ≥18.5 and <30). If the sex term was found to be significant, separate models were fitted to each sex. Conversely, if the race/ethnicity term was found to be insignificant, the models were simplified by omitting the term from the model.
To assess the impact of considering the FFMI percentiles constant across age for those 25 years and older, the maximum percent change was computed separately for males and females, with BMI unrestricted and restricted. First, empirical FFMI quantiles were obtained for each of the age groups defined by the half-closed intervals [a,b) = {x | a ≤ x < b} resulting from the following cut-points: 12[2]20 [5] 80. For example, let q i denote the median (50% quantile) for the ith age group. Second, the percent change between any 2 such medians q i , q j across age groups was computed as ∆ A table for individual FFMI for each percentile from 1-99 by sex was constructed so that it could be used to quantify a value for individual patients.
All P values are 2-sided; P < .05 was used as the criterion for significance. Statistical modeling was done with the quantreg package version 4.08 13 in R for Windows version 2.5.1 patched.
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Results
The initial data set includes all participants aged 12 to >90 years with values for resistance at 50 kHz, height, weight, and BMI along with age, sex, and race/ethnicity of non-Hispanic white, non-Hispanic black, and Mexican American (data not shown). The race/ethnicity distribution of the males and females younger than age 50 years reflects the oversampling of non-Hispanic black and Mexican American participants for NHANES III. 7 The male and female participants older than age 50 years with BIA data were predominantly non-Hispanic white.
Evaluation of Sex Differences in FFMI
Sex differences were statistically significant for all percentiles (P < .001), with women having significantly lower FFMI quantiles than the corresponding ones for males. Due to this difference, males and females were modeled separately. Separate modeling was done in both the BMI unrestricted and restricted analyses.
Evaluation of FFMI With and Without BMI Restrictions
With no restrictions on BMI in males ( Figure 1A ) and females ( Figure 1B) , FFMI significantly increased between ages 15 and 23 years due to adolescent growth. Between 25 and 80 years of age, there were significant increases in FFMI, with peaks between 40 and 50 years of age, which then decreased to age 80 (P < .05). These data include 8217 males and 8690 females, for a total of 16,907 participants. Figure 1 shows the 2.5th, 5th, 10th . . . 97.5th percentiles for FFMI over these age groups, and the peak at 40-50 years of age is very evident.
To assess whether extremely thin or obese patients altered these percentiles, we reanalyzed the data and excluded patients with a BMI <18.5 or >30 kg/m 2 in male ( Figure 2A ) and female ( Figure 2B ) participants. These figures represent 6495 males and 6062 females for a total of 12,557 participants. Again, FFMI significantly differed across sex (P < .001). In these weight-restricted populations, significant increases in FFMI occurred between ages 15 and 23 years as expected due to growth during the adolescent and early adult years. However, FFMI values remained relatively stable between ages 25 and 80 years in both males and females in this restricted population, flattening the peak between 40 and 50 years of age seen in the unrestricted populations. Although some curvature still exists with a peak at approximately 50 years of age, the maximum percent difference is at most 4.95% and 6.18% at any age point on any percentile line for males and females, respectively (or about 1 kg/m 2 ), between ages 25 and 80 years. The average percent differences are 4.23% and 3.68% for males and females, respectively.
Evaluation of FFMI and Race/Ethnicity
Unrestricted by BMI Males. When BMI was unrestricted, FFMI quantiles for Mexican American males were not significantly different from those of non-Hispanic white males (P ≥ .493, for all quantiles). However, non-Hispanic black males had significantly different FFMI quantiles from those of non-Hispanic white males (P < .003) except for the median and third quartile (P = .236 and P = .317, respectively). The quantiles up to the first quartile inclusive (2.5%, 5%, 10%, and 25%) of non-Hispanic black males were lower than those of their non-Hispanic white counterparts, while the direction was reversed for quantiles above the third quartile (90%, 95%, 97.5%).
Females. When BMI was unrestricted, non-Hispanic black females had higher FFMI quantiles than those of their nonHispanic white peers (P < .002) for percentiles above the 5th percentile. Similarly, Mexican American females had higher quantiles than did non-Hispanic white females (P < .001) for quantiles up to the 90th percentile.
Restricted by BMI
Males. When BMI was restricted (18.5 ≤ BMI < 30), the race effects were significant for non-Hispanic black males up to the third quartile (P < .05), while no differences were seen for Mexican American males for the 10th-90th percentilesthat is, significant differences were seen only at the tails (2.5%, 95.0%, and 97.5%). Non-Hispanic white males consistently had significantly higher FFMI than did Mexican American males, who in turn had significantly higher FFMI than did nonHispanic black males between the 10th and 50th percentiles (P < .05). However, the maximum percentage difference ranged between 1.3% and 4.75%, which is likely not clinically relevant to warrant differentiation by race/ethnicity.
Females. The restricted FFMI of non-Hispanic black females was significantly greater than that of non-Hispanic white females between the 50th and 95th percentiles but not below the 50th percentile or at the upper tail. Mexican American females differed from their non-Hispanic white counterparts from the 10th-90th percentiles (P < .05) but not at the extremes. The differences varied between 1.3% and a maximum of 3.75% at various percentiles.
Percentile Values by Sex
Individual data for FFMI restricted by weight for each decile by sex but not ethnicity are provided in Table 1 . Data are limited to patients 25-69 years of age.
Discussion
Preexisting malnutrition of surgical patients is associated with increased complication rates, [15] [16] [17] [18] [19] [20] higher mortality and morbidity, [21] [22] [23] [24] [25] increased hospital length of stay, 6, 26, 27 and increased healthcare costs. 25, 26, 28 Unfortunately, preoperative identification of these patients is complicated due to (1) a general shift to outpatient evaluation with admission on the day of surgery 29 and (2) the inability to cost-effectively identify alterations in nutrition status and existing deficiencies in lean tissue mass. This work defines a template against which measurement of FFM with BIA allows stratification of an individual patient's values compared with the general U.S. population. It also allows for systematic quantification of changes in a patient's FFM and FFMI associated with age, surgical procedure, or development of complications.
BIA uses physical properties of the body to measure drops of voltage due to the impedance from tissues; this technique is portable, low cost, and low risk. Single-frequency BIA at 50 kHz can estimate total body water based on extracellular water as well as FFM. FFMI allows the FFM to be indexed by height. Unfortunately, data from these European studies include a uniform race/ethnicity and weights that are not representative of the U.S. population. Schutz et al 31 postulated that the FFM regression equations generated within one population might not be applicable to another population, which Kyle et al 32 confirmed by demonstrating discrepancies in FFM between BIA equations generated specifically from the Swiss population and the U.S. population NHANES III cohort evaluated here. Since this study evaluates U.S.-specific data from a large nationally representative data set, we chose to use the FFM regression equations developed from this exact data by Sun et al 9 and Chumlea et al 10 to generate American age-and race/ ethnicity-independent FFMI values, precluding use of an equation that was developed for a different population.
In expectation of using this technique in subsequent prospective studies, we analyzed a large population of data from the NHANES III database to produce a template for individual patient comparison. We limited our analysis to patients with BIA and simultaneous height and weight since Pichard et al 6 and Schutz et al 31 showed the importance of normalizing FFM data by height. We reached several conclusions in our analysis. First, FFMI differs for males and females; therefore, a percentile range reflecting the U.S. population should be presented by sex. Second, extremes in the BMI reflecting obesity (BMI >30) or extreme asthenia (BMI <18.5) should be analyzed separately from the general population. Third, FFMI increases dramatically in adolescence through young adulthood. However, between 25 and 80 years of age, the FFMI remains relatively stable by percentile. Alterations that occur beyond this age are probably secondary to the decreasing size of the study population. Although some statistical variations occur, these appear of relatively insignificant magnitude. Fourth, between ages 25 and 80 years, while there are differences in FFMI at a given percentile between non-Hispanic whites, non-Hispanic blacks, and Mexican Americans, these variations also appear clinically insignificant. Thus, separate percentile tables and figures do not need to be generated based on race/ethnicity.
These conclusions are consistent with other Americanspecific published work. Chumlea et al 10 described the FFM, total body water, percent body fat, and total body fat in the same NHANES III population (ages 12-80 years). They concluded that FFM was greater in males than in females and increased with age in adolescents and found that FFM differed by race/ethnicity (males: non-Hispanic white > non-Hispanic black > Mexican American; females: non-Hispanic black > non-Hispanic white > Mexican American). Forbes 33 noted that the FFM of both sexes increased during the adolescent years but remained stable in those older than 20 years. The authors of these studies did not index their values to height, however.
Our data differed in several regards to other trials. Gallagher et al 34 and Kyle et al 32 noted decreases in FFM with increasing age while we did not detect a significant decrease in FFMI, possibly due to decreased height associated with advancing age. The NHANES III anthropometric reference data (Advance Data No. 347) reveal an average height decrease of 5.4 cm for males and 6.6 cm for females between the age groups of 20-29 years and 75 years and older. A 10% decrease in FFM across these 2 age groups with different average heights would result in only a small decrease in FFMI, as we observed, rather than the pronounced decreases found by Kyle FFMI (60th to 40th) . Outcomes could be stratified by percentile change in FFMI to determine the metabolic expense of the therapy or subsequently the effect of a nutrition intervention on outcomes. The same device would be necessary for both pretreatment and posttreatment measurements. an individual's lean tissue compares with the U.S. population, while FFM does not. It is also possible, however, that with regard to identifying patients who are at greater risk for postsurgical complications, FFMI may mask a low part of the atrisk population despite making it easier to adjust for differences in BMI for height.
The clinical implications of these observations are important. First, in recruiting patients into randomized prospective studies, patients within the appropriate BMI ranges can add accurate determination of their FFMI for appropriate stratification between the 2.5th and 97.5th percentiles. This stratification will allow investigation of how altered protein mass (measured through its surrogate FFMI) affects outcome. Second, this technique can allow examination of the physiologic cost (loss of protein mass) of specific medical interventions and the physiologic cost of associated complications. As an example, we recently examined the effect of radiation and chemotherapy as a treatment for esophageal carcinoma. Patients who lost weight with treatment dropped their FFMI from 19.8 ± 1.1 kg/m 2 to 18.4 ± 1.4 kg/m 2 , representing more than an 18% decrease in FFMI compared with the U.S. population. Hopefully, just as height/age figures for young children allow prediction of the final height of that individual in adulthood, the FFMI scale can be used as a means to identify, stratify, and then treat preexisting malnutrition.
We recognize that the current BIA technology may be superior to the BIA technology used in the NHANES III study. However, the principles in this data analysis should remain constant despite these improvements. Our conclusions from this analysis are as follows: (1) The range of FFMI should exclude extremes in BMI (malnutrition or obesity) to represent true normal distribution of FFMI without the influence of extreme weights. (2) FFMI differs for males and females, and a percentile range, reflecting the U.S. population, should be presented by sex. (3) FFMIs (adjusted for extremes of BMI) are similar for both sexes of non-Hispanic whites, non-Hispanic blacks, and Mexican Americans so the FFMIs of these race/ethnicities can be combined by sex. (4) The FFMI percentiles can be collapsed into the following age groups: (a) 12-20 every 2 years, (b) 20-25 years, (c) 25-80 years, and (d) >80 years. From these data, FFMI appears stable across the age groups most likely to be entered into adult clinical trials, thus allowing interpretation of the FFMI (and its changes) measured in each patient.
